Chinese prosecutors have brought formal charges against AstraZeneca and its former executives following investigations into alleged illegal patient data collection and importation of drugs.
The prosecutor in the southern Chinese city of Shenzhen has indicted an AstraZeneca subsidiary in China, a former executive vice president, and another former senior employee, according to AZ. … The two former execs also face additional charges of medical insurance fraud, according to the company.
The case has been consolidated into one proceeding, with no trial date set yet…
The former head of AZN operations in China, who was detained in 2024 (#msg-175353326), is one of the indicted.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”